| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Division of Toxicological Sciences, Department of Environmental Health Sciences, School of Hygiene and Public Health, The Johns Hopkins University, Baltimore, Maryland 21205 [H. H., M. A. T.], and Gene Expression and Aging Section, National Institute on Aging, NIH, Baltimore, Maryland 21224 [X. W., M. G., N. J. H.]
The purpose of this study was to evaluate whether the mitogen-activated protein kinase (MAPK) signaling pathway contributes to 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced mononuclear differentiation in the human myeloblastic leukemia ML-1 cells. Upon TPA treatment, the activity of ERK1 and ERK2 rapidly increased, with maximal induction between 1 and 3 h, while ERK2 protein levels remained constant. The activity of JNK1 was also significantly induced, with JNK1 protein levels increasing moderately during exposure to TPA. Treatment of cells with PD98059, a specific inhibitor of mitogen-activated protein kinase kinase (MEK), inhibited TPA-induced ERK2 activity. Furthermore, PD98059 completely blocked the TPA-induced differentiation of ML-1 cells, as assessed by a number of features associated with mononuclear differentiation including changes in morphology, nonspecific esterase activity, phagocytic ability, NADPH oxidase activity, mitochondrial respiration, and c-jun mRNA inducibility. We conclude that activation of the MEK/ERK signaling pathway is necessary for TPA-induced mononuclear cell differentiation.
This article has been cited by other articles:
![]() |
A. V. Woodard-Grice, A. C. McBrayer, J. K. Wakefield, Y. Zhuo, and S. L. Bellis Proteolytic Shedding of ST6Gal-I by BACE1 Regulates the Glycosylation and Function of {alpha}4{beta}1 Integrins J. Biol. Chem., September 26, 2008; 283(39): 26364 - 26373. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. Seales, F. M. Shaikh, A. V. Woodard-Grice, P. Aggarwal, A. C. McBrayer, K. M. Hennessy, and S. L. Bellis A Protein Kinase C/Ras/ERK Signaling Pathway Activates Myeloid Fibronectin Receptors by Altering {beta}1 Integrin Sialylation J. Biol. Chem., November 11, 2005; 280(45): 37610 - 37615. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Wang, Y.-C. Hu, S. Dong, M. Fan, D. Tamae, M. Ozeki, Q. Gao, D. Gius, and J. J. Li Co-activation of ERK, NF-{kappa}B, and GADD45{beta} in Response to Ionizing Radiation J. Biol. Chem., April 1, 2005; 280(13): 12593 - 12601. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-M. Lai, S. Wu, D.-Y. Huang, and Z.-F. Chang Cytosolic Retention of Phosphorylated Extracellular Signal-Regulated Kinase and a Rho-Associated Kinase-Mediated Signal Impair Expression of p21Cip1/Waf1 in Phorbol 12-Myristate-13- Acetate-Induced Apoptotic Cells Mol. Cell. Biol., November 1, 2002; 22(21): 7581 - 7592. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Roach and J. S. Schorey Differential Regulation of the Mitogen-Activated Protein Kinases by Pathogenic and Nonpathogenic Mycobacteria Infect. Immun., June 1, 2002; 70(6): 3040 - 3052. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wang, J. L. Martindale, and N. J. Holbrook Requirement for ERK Activation in Cisplatin-induced Apoptosis J. Biol. Chem., December 8, 2000; 275(50): 39435 - 39443. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. L. Deszo, D. K. Brake, K. A. Cengel, K. W. Kelley, and G. G. Freund CD45 Negatively Regulates Monocytic Cell Differentiation by Inhibiting Phorbol 12-Myristate 13-Acetate-dependent Activation and Tyrosine Phosphorylation of Protein Kinase Cdelta J. Biol. Chem., March 23, 2001; 276(13): 10212 - 10217. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |